ETTA FRANKEL, M.D.
Hematology & Oncology Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
ETTA FRANKEL, M.D. filed 5,216 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in NEW YORK, New York, prescribing 86% generic.
- 5K
- Part D claims, 2023
- 86%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
ETTA FRANKEL, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
5,216 Top 6% higher than 94% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
ETTA FRANKEL, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about ETTA FRANKEL, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in New York
How Hematology & Oncology Physician compares to other specialties among New York providers
Hematology & Oncology Physician share within New York
Hematology & Oncology Physician is one of the more visible NUCC categories in New York
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Hematology & Oncology Physician ABMS/AOA estimate
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Hematology & Oncology Physician US NPIs
Specialty board-certified rate — Hematology & Oncology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ETTA FRANKEL, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 2109 BROADWAY, NEW YORK, NY, 10023, with a listed phone of (212) 523-8672. NPI 1952394967 was issued on 08/24/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FRANKEL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 5,216 prescription claims written by this provider, covering 504 Medicare beneficiaries and totaling roughly $1.5 million in drug spend, split 14% brand-name and 86% generic by claim count, with an opioid prescribing rate of 0.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1952394967 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 08/24/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ETTA FRANKEL, M.D.'s current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where ETTA FRANKEL, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context — New York NYSBPMC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to ETTA FRANKEL, M.D.. To verify ETTA FRANKEL, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
14% brand-name claims vs 86% generic, on 5,216 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 12,485
- Total Day Supply
- 366,589
- Brand vs Generic
- 14% brand / 86% generic
- Brand Drug Cost
- $1.4M
- Generic Drug Cost
- $91K
- Opioid Claims
- 49 (0.9% rate)
- Antibiotic Claims
- 132
Patient Demographics
- Average Patient Age
- 75.2 years
- Avg HCC Risk Score
- 1.09
- Gender Split
- 74% female / 26% male
- Age Distribution
- <65: 24, 65-74: 236, 75-84: 174, 85+: 70
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What ETTA FRANKEL, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
557 claims
- Amlodipine Besylate
Amlodipine Besylate
381 claims
- Losartan Potassium
Losartan Potassium
359 claims
- Lisinopril
Lisinopril
282 claims
- Levothyroxine Sodium
Levothyroxine Sodium
242 claims
- Metoprolol Succinate
Metoprolol Succinate
230 claims
- Hydrochlorothiazide 190
Hydrochlorothiazide
190 claims
- Metformin Hcl Er 171
Metformin Hcl Er
171 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 557 |
| Amlodipine Besylate | 381 |
| Losartan Potassium | 359 |
| Lisinopril | 282 |
| Levothyroxine Sodium | 242 |
| Metoprolol Succinate | 230 |
| Hydrochlorothiazide | 190 |
| Metformin Hcl Er Metformin Hcl | 171 |
| Rosuvastatin Calcium | 150 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 111 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How ETTA FRANKEL, M.D. fits within the Hematology & Oncology Physician landscape nationally.
ETTA FRANKEL, M.D.'s 5,216 claims are above the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as FRANKEL.
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New York
Frequently Asked Questions
What is ETTA FRANKEL, M.D.'s specialty? ▼
How much does ETTA FRANKEL, M.D. prescribe under Medicare Part D? ▼
Where is ETTA FRANKEL, M.D. located? ▼
What is ETTA FRANKEL, M.D.'s NPI number? ▼
Does ETTA FRANKEL, M.D. prescribe more brand-name or generic drugs? ▼
Does ETTA FRANKEL, M.D. prescribe opioids? ▼
How many Hematology & Oncology Physician providers are there in the US? ▼
What drugs does ETTA FRANKEL, M.D. prescribe most often? ▼
Does ETTA FRANKEL, M.D. accept Medicare? ▼
How can I verify ETTA FRANKEL, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology